Nano Vision | Turn the Tide Against Global Health Threats

Heal the World

Dramatically accelerating mankind’s understanding of health to prevent, treat and ultimately cure disease.

Featured In

View all Press

Updating an Outdated Model

Today, our approach to fighting global health threats is not working. Many dangerous illnesses still lack efficient prevention or treatment options and continue to affect millions of people every day. A single clinical trial can cost between $800 million and $1.4 billion, but 90% of them end in failure. Critical data exists in silos around the world, limiting scientific progress. Globally, we spend around $7 trillion each year on healthcare. We’re clearly facing a major imbalance in our system.

90% of Clinical Trials Fail

Nano Vision Platform

Bringing technology to life at the nanoscale in order to create a safer, healthier world.

Nano Sense™

Enabling the real-time stream of molecular data.

Cure Chain ™

Nano's distributed ledger technology.

Inference Engine

AI-based operating system across Nano devices and data.

Nano Sense™ and Real-Time, Real-World Data

Being developed in partnership with affiliate Nano Global Corporation and Arm, the leading semiconductor IP company, the devices and chip collect and analyze molecular data, a critical subset of biological information in real time, increasing the amount of available data by orders of magnitude.

Nano Cure Chain™

Nano’s distributed ledger technology, called Cure Chain™, secures and attributes all data to its correct, original source.

The Inference Engine: Artificial Intelligence & Machine Learning

Forming one of the world's largest datasets, the continuous and massive collection of biological data will enable our artificial intelligence and machine learning systems to act as an inference engine. By identifying trends and drawing conclusions, this inference engine will give the world's brightest minds an entirely new tool to create life-saving solutions.

Initial Health Threat Targets

In partnership with teams at leading research, academic and healthcare institutions, Nano Vision is planning to accelerate the collection and population of key research associated with:

Worldwide infectious diseases

Tuberculosis
Zika
Malaria
Dengue
Chagas

Research and treatments to combat antimicrobial resistance (AMR)

We have several efforts underway including the development of technology and products to avoid perpetrating AMR/Superbugs

Virology research and treatments for

Hepatitis B & C
Influenza A & B
Respiratory syncytial virus

Bacteriology research and treatments for

Methicillin-resistant Staphylococcus aureus (MRSA)
Clostridium difficile (C. Diff)

Neurology research and treatments for

Alzheimer’s disease
Diabetes
Pancreatic Cancer
Cardiovascular Disease